Business Description
Korea United Pharm Inc
NAICS : 325412
ISIN : KR7033270000
Share Class Description:
XKRX:033270: Ordinary SharesCompare
Compare
Traded in other countries / regions
033270.Korea IPO Date
1999-11-11Description
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.59 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.34 | |||||
| Interest Coverage | 23.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.2 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.3 | |||||
| 3-Year EBITDA Growth Rate | 17.5 | |||||
| 3-Year EPS without NRI Growth Rate | 22.4 | |||||
| 3-Year FCF Growth Rate | -8.6 | |||||
| 3-Year Book Growth Rate | 11.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 3.17 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 7.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.12 | |||||
| 9-Day RSI | 49.41 | |||||
| 14-Day RSI | 47.18 | |||||
| 6-1 Month Momentum % | -15.79 | |||||
| 12-1 Month Momentum % | -16.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.07 | |||||
| Quick Ratio | 2.3 | |||||
| Cash Ratio | 1.68 | |||||
| Days Inventory | 158.9 | |||||
| Days Sales Outstanding | 56.77 | |||||
| Days Payable | 35.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| 3-Year Dividend Growth Rate | 6.3 | |||||
| Forward Dividend Yield % | 2 | |||||
| 5-Year Yield-on-Cost % | 2.63 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 2.47 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.07 | |||||
| Operating Margin % | 11.52 | |||||
| Net Margin % | 11.28 | |||||
| FCF Margin % | 7.82 | |||||
| ROE % | 8.52 | |||||
| ROA % | 6.82 | |||||
| ROIC % | 8.83 | |||||
| 3-Year ROIIC % | 26.67 | |||||
| ROC (Joel Greenblatt) % | 20.97 | |||||
| ROCE % | 10.39 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.54 | |||||
| Forward PE Ratio | 5.42 | |||||
| PE Ratio without NRI | 7.8 | |||||
| Price-to-Owner-Earnings | 5.76 | |||||
| PEG Ratio | 0.87 | |||||
| PS Ratio | 1.08 | |||||
| PB Ratio | 0.8 | |||||
| Price-to-Tangible-Book | 0.82 | |||||
| Price-to-Free-Cash-Flow | 13.86 | |||||
| Price-to-Operating-Cash-Flow | 5.74 | |||||
| EV-to-EBIT | 4.68 | |||||
| EV-to-EBITDA | 3.73 | |||||
| EV-to-Revenue | 0.67 | |||||
| EV-to-FCF | 8.36 | |||||
| Price-to-Projected-FCF | 0.55 | |||||
| Price-to-DCF (Earnings Based) | 0.34 | |||||
| Price-to-DCF (FCF Based) | 0.4 | |||||
| Price-to-Median-PS-Value | 0.63 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.81 | |||||
| Price-to-Graham-Number | 0.53 | |||||
| Price-to-Net-Current-Asset-Value | 2.12 | |||||
| Price-to-Net-Cash | 9 | |||||
| Earnings Yield (Greenblatt) % | 21.36 | |||||
| FCF Yield % | 7.24 | |||||
| Forward Rate of Return (Yacktman) % | 18.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korea United Pharm Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 285,776.15 | ||
| EPS (TTM) (â‚©) | 2202 | ||
| Beta | 0.65 | ||
| Volatility % | 20.95 | ||
| 14-Day RSI | 47.18 | ||
| 14-Day ATR (â‚©) | 518.6874 | ||
| 20-Day SMA (â‚©) | 21060 | ||
| 12-1 Month Momentum % | -16.47 | ||
| 52-Week Range (â‚©) | 20000 - 28900 | ||
| Shares Outstanding (Mil) | 14.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korea United Pharm Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korea United Pharm Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korea United Pharm Inc Frequently Asked Questions
What is Korea United Pharm Inc(XKRX:033270)'s stock price today?
The current price of XKRX:033270 is â‚©21000.00. The 52 week high of XKRX:033270 is â‚©28900.00 and 52 week low is â‚©20000.00.
When is next earnings date of Korea United Pharm Inc(XKRX:033270)?
The next earnings date of Korea United Pharm Inc(XKRX:033270) is .
Does Korea United Pharm Inc(XKRX:033270) pay dividends? If so, how much?
The Dividend Yield %  of Korea United Pharm Inc(XKRX:033270) is 2% (As of Today), Highest Dividend Payout Ratio of Korea United Pharm Inc(XKRX:033270) was 0.19. The lowest was 0.12. And the median was 0.16. The  Forward Dividend Yield % of Korea United Pharm Inc(XKRX:033270) is 2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers